2 weeks Ago
mohd izzuan Humacyte ( NASDAQ: HUMA ) shares hit a record low of $1.76 in Friday trading despite releasing Q4 2024 financial results that beat on the bottom line. The stock is off ~7% .
GAAP EPS of -$0.16 bested consensus expectation of -$0.25.
Humacyte has.
